Shyam Nyati
7PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 16, 2024
BUB1 Inhibition Overcomes Radio- and Chemoradiation Resistance in Lung Cancer.Shivani Thoidingjam, Sushmitha Sriramulu, Oudai Hassan
|Oct 16, 2024
Present and Future of Immunotherapy for Triple-Negative Breast Cancer.Sushmitha Sriramulu, Shivani Thoidingjam, Corey Speers
|Sep 28, 2024
Optimizing Pancreatic Cancer Therapy: The Promise of Immune Stimulatory Oncolytic Viruses.Shivani Thoidingjam, Aseem Rai Bhatnagar, Sushmitha Sriramulu
|Jun 27, 2024
BUB1 Inhibition Sensitizes TNBC Cell Lines to Chemotherapy and Radiotherapy.Sushmitha Sriramulu, Shivani Thoidingjam, Farzan Siddiqui
|May 25, 2024
Long-Term Follow-Up of Phase I Trial of Oncolytic Adenovirus-Mediated Cytotoxic and Interleukin-12 Gene Therapy for Treatment of Metastatic Pancreatic Cancer.Aseem Rai Bhatnagar, Farzan Siddiqui, Gazala Khan
|Sep 15, 2023
A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma.Shyam Nyati, Hans Stricker, Kenneth N Barton
Pageof 2
